U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07419113) titled 'Development of an Integrated Multi-channel Artificial Nose for Cancer Detection (UNos)' on Feb. 03.
Brief Summary: Exhaled breath analysis using E-Nose sensors detects molecular fingerprints and shows promise for early cancer detection.
Study Start Date: Feb. 01, 2023
Study Type: INTERVENTIONAL
Condition:
Head and Neck Cancer
Intervention:
DEVICE: Artificial or Electronic Nose (E-Nose) medical device
medical device detecting breathe-out molecules
Recruitment Status: COMPLETED
Sponsor: Institute of Oncology Ljubljana
Disclaimer: Curated by HT Syndication....